2m 2m 2m 2m 2m 2m 2m
SAB BIOTHERAP (SABS)
NASDAQ
$2.97-$0.08 (-2.47%)
Price as of Oct 22, 2026 7:30 PM EDT- $256.6MMarket Cap
- 4.11%1-Year Change
- BiotechnologyIndustry
SAB BIOTHERAP (SABS)
$2.97-$0.08 (-2.47%)
Earnings Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.31% | ||
12-Month Momentum | 13.00% | ||
3-Month Risk Adjusted Momentum | -34.19% | ||
12-Month Risk Adjusted Momentum | 22.94% |
True Yield
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.60% |
Financial Health Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |